Living with chronic pain is exhausting—physically, emotionally, and mentally. When pain lasts longer than three to six months and continues despite medications, injections, physical therapy, or even surgery, it becomes more than a symptom. It becomes a condition that affects how you sleep, move, work, and connect with the people around you.
Over time, chronic pain can lead to deconditioning, anxiety, depression, and a sense of hopelessness. Many people find themselves relying more heavily on medications, including opioids, while still feeling that their pain controls their life. At this stage, treating pain often requires a different approach—one that focuses not just on symptoms, but on how the nervous system processes pain signals.
This is where neuromodulation, including Spinal Cord Stimulation (SCS) and, in select cases, Peripheral Nerve Stimulation (PNS), plays an important role in Medtronic’s pain management pathway.
Medtronic’s SCS therapy typically begins with a trial phase, allowing patients to experience stimulation before committing to a permanent implant. This trial helps determine whether the therapy provides meaningful pain relief and functional improvement.
Spinal Cord Stimulation (SCS) is a therapy that delivers mild electrical stimulation to the spinal cord through small implanted leads. These signals help modify how pain messages are transmitted to the brain, reducing the perception of pain and allowing patients to regain function and quality of life. Medtronic offers advanced SCS systems, including the Inceptiv™ and Intellis™ Pro platforms, designed for long-term management of chronic, intractable pain of the trunk and limbs.
While Medtronic’s primary focus is SCS, neuromodulation as a field also includes Peripheral Nerve Stimulation (PNS), which targets specific nerves outside the spinal cord when pain originates from a peripheral nerve source.
Medtronic emphasizes breadth and innovation in pain care. Their SCS systems feature advanced technologies such as closed-loop stimulation, rechargeable designs, and full-body MRI compatibility—important considerations for patients managing chronic conditions over many years. Medtronic also offers additional pain therapies, such as Targeted Drug Delivery, allowing care teams to tailor treatment when stimulation alone is not enough.
For the right patient, SCS can offer more than pain relief. Many people experience improved mobility, better sleep, increased participation in daily activities, and a renewed sense of control. By reducing pain intensity, neuromodulation may also help ease the emotional burden of chronic pain and support reduced reliance on systemic medications, including opioids.
Medtronic SCS systems are indicated for chronic, intractable pain of the trunk and/or limbs, including painful diabetic peripheral neuropathy (DPN) of the lower extremities—an indication specifically highlighted in Medtronic’s pain management portfolio.
Your journey starts with a detailed evaluation by a pain specialist. During the trial, you track how stimulation affects pain, movement, sleep, and daily life.
If the trial is successful, a permanent SCS system is implanted. Patients receive education on device use, programming, and follow-up care.
SCS therapy continues beyond implantation. Follow-up visits allow for programming optimization and integration with rehabilitation and lifestyle strategies to support long-term success.
Medtronic patient education materials help explain chronic pain, how SCS works, what to expect during the trial and implant process, and questions to discuss with a pain specialist—empowering patients to take an active role in their care.
Chronic pain doesn’t have to be the end of the story. For carefully selected patients, Medtronic’s Spinal Cord Stimulation therapy offers a proven, technology-driven path toward pain relief, improved function, and a better quality of life.